Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Staedke, Sarah G ^a,b   Jagannathan, Prasanna ^c   Yeka, Adoke ^d   Bukirwa, Hasifa ^d   Banek, Kristin ^d   Maiteki Sebuguzi, Catherine ^e   Clark, Tamara D ^c   Nzarubara, Bridget ^e   Njama Meya, Denise ^e   Mpimbaza, Arthur ^e   Rosenthal, Philip J ^c   Kamya, Moses R ^e   Wabwire Mangen, Fred ^f   Dorsey, Grant ^b   Talisuna, Ambrose O ^g  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MULAGO HOSPITAL   (Uganda)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Uganda Malaria Surveillance Project   (Uganda)

^e MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^f MAKERERE UNIVERSITY   (Uganda)

^g MINISTRY OF HEALTH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; AMODIAQUINE PLUS FANSIDAR; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; CHLOROQUINE PLUS FANSIDAR; DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ;

ANEMIA; ARTICLE; CASE STUDY; CLINICAL TRIAL; CONVULSION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FOLLOW UP; HUMAN; LABORATORY TEST; MALARIA; MENTAL DISEASE; NEUROTOXICITY; NEUTROPENIA; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TIME SERIES ANALYSIS; TREATMENT FAILURE; UGANDA; VOMITING; WEAKNESS; WORLD HEALTH ORGANIZATION; CHILD; DRUG COMBINATION; INFANT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; HUMANS; INFANT; MALARIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; UGANDA;

EID: 47349101022     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-107     Document Type: Article

References (27)

1. Artemisinin-based combination treatment of falciparum malaria. F Nosten N White, Am J Trop Med Hyg 2007 77 Suppl 6 181 192
2. The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa. O Simooya, Drug Saf 2005 28 4 277 286 10.2165/00002018- 200528040-00001 15783238
3. A major transition in malaria treatment: The adoption and deployment of artemisinin-based combination therapies. A Bosman KM Mendis, Am J Trop Med Hyg 2007 77 Suppl 6 193 197
4. Efficacy and safety of dihydroartemisinin-piperaquine. HY Myint EA Ashley NP Day F Nosten NJ White, Trans R Soc Trop Med Hyg 2007 101 9 858 866 10.1016/j.trstmh.2007.05.018 17659311
5. Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial. MR Kamya A Yeka H Bukirwa M Lugemwa JB Rwakimari SG Staedke AO Talisuna B Greenhouse F Nosten PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Clin Trials 2007 2 5 e20 17525792 10.1371/journal.pctr.0020020
6. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. C Karema CI Fanello C Van Overmeir JP Van Geertruyden W van Doren D Ngamije U D'Alessandro, Trans R Soc Trop Med Hyg 2006 100 12 1105 1111 10.1016/j.trstmh.2006.01.001 16766006
7. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. World Health Organization, Technical Report Series Geneva, WHO Division of Control of Tropical Diseases 1996
8. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. World Health Organization, Geneva 2003 WHO/HTM/RBM/2003.50 WHO/CDS/CSR/EPH/2002.17 WHO/CDS/RBM/2002.39
9. Susceptibility of Plasmodium falciparum to antimalarial drugs: report on global monitoring 1996-2004. World Health Organization, Geneva, World Health Organization 2005
10. Pharmacovigilance of antimalarial treatment in Africa: is it possible? AO Talisuna SG Staedke U D'Alessandro, Malar J 2006 5 50 16780575 10.1186/1475-2875-5-50
11. Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa. U Mehta D Durrheim A Mabuza L Blumberg E Allen KI Barnes, Drug Saf 2007 30 10 899 910 17867727
12. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. M Adjuik P Agnamey A Babiker S Borrmann P Brasseur M Cisse F Cobelens S Diallo JF Faucher P Garner S Gikunda PG Kremsner S Krishna B Lell M Loolpapit PB Matsiegui MA Missinou J Mwanza F Ntoumi P Olliaro P Osimbo P Rezbach E Some WR Taylor, Lancet 2002 359 9315 1365 1372 10.1016/S0140-6736(02)08348-4 11978332
13. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda. CI Fanello C Karema W van Doren C Van Overmeir D Ngamije U D'Alessandro, Trans R Soc Trop Med Hyg 2007 101 4 344 350 10.1016/j.trstmh.2006.06.010 17005222
14. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallett J Ahmed C Drakeley BM Greenwood CJ Whitty, Lancet 2005 365 9469 1474 1480 10.1016/S0140-6736(05)66417-3 15850631
15. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. H Bukirwa A Yeka MR Kamya A Talisuna K Banek N Bakyaita JB Rwakimari PJ Rosenthal F Wabwire-Mangen G Dorsey SG Staedke, PLoS Clin Trials 2006 1 1 e7 16871329 10.1371/journal.pctr.0010007
16. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. SG Staedke A Mpimbaza MR Kamya BK Nzarubara G Dorsey PJ Rosenthal, Lancet 2004 364 9449 1950 1957 10.1016/S0140-6736(04) 17478-3 15567011
17. Sulfadoxine-pyrimethamine plus chloroquine or amodiaquine for uncomplicated falciparum malaria: a randomized, multisite trial to guide national policy in Uganda. N Bakyaita G Dorsey A Yeka K Banek SG Staedke MR Kamya A Talisuna F Kironde S Nsobya A Kilian A Reingold PJ Rosenthal F Wabwire-Mangen, Am J Trop Med Hyg 2005 72 5 573 580 15891132
18. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. A Yeka K Banek N Bakyaita SG Staedke MR Kamya A Talisuna F Kironde SL Nsobya A Kilian M Slater A Reingold PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Med 2005 2 7 e190 16033307 10.1371/journal.pmed.0020190
19. Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment. JC Davis TD Clark SK Kemble N Talemwa D Njama-Meya SG Staedke G Dorsey, Malar J 2006 5 18 16551365 10.1186/1475-2875-5-18
20. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. G Dorsey S Staedke TD Clark D Njama-Meya B Nzarubara C Maiteki-Sebuguzi C Dokomajilar MR Kamya PJ Rosenthal, Jama 2007 297 20 2210 2219 10.1001/jama.297.20.2210 17519410
21. Variation in malaria transmission intensity in seven sites throughout Uganda. PE Okello VANB W AM Byaruhanga A Correwyn P Roelants A Talisuna U D'Alessandro M Coosemans, Am J Trop Med Hyg 2006 75 2 219 225 16896122
22. Guidance for Industry: Good Clinical Practice: Consolidated Guidance (ICH-E6). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Rockville, MD, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) 1996
23. Artemisinin: mechanisms of action, resistance and toxicity. SR Meshnick, Int J Parasitol 2002 32 13 1655 1660 10.1016/S0020-7519(02)00194-7 12435450
24. Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults. CI Fanello C Karema W van Doren CE Rwagacondo U D'Alessandro, Trop Med Int Health 2006 11 5 589 596 10.1111/j.1365-3156.2006.01610.x 16640610
25. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. M Makanga Z Premji C Falade J Karbwang EA Mueller K Andriano P Hunt PI De Palacios, Am J Trop Med Hyg 2006 74 6 991 998 16760509
26. The importance of pharmacovigilance: safety monitoring of medicinal products. World Health Organization, Geneva 2002
27. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. C Maiteki-Sebuguzi P Jagannathan VM Yau TD Clark D Njama-Meya B Nzarubara AO Talisuna MR Kamya PJ Rosenthal G Dorsey SG Staedke, Malaria J 2008 7 106 10.1186/1475-2875-7-106